{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:25:06Z","timestamp":1790623506293,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Innlandet Hospital Trrust","award":["150323"],"award-info":[{"award-number":["150323"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1439-1","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T07:02:42Z","timestamp":1508223762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6143-1600","authenticated-orcid":false,"given":"Gia","family":"Deyab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Hokstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Elling","family":"Whist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milada Cvancarova","family":"Smastuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Agewall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torstein","family":"Lyberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Ronda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnbjorg","family":"Hjeltnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Hollan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,17]]},"reference":[{"issue":"10","key":"1439_CR1","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.autrev.2013.03.013","volume":"12","author":"I Hollan","year":"2013","unstructured":"Hollan I, Meroni PL, Ahearn JM, Cohen Tervaert JW, Curran S, Goodyear CS, et al. Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev. 2013;12(10):1004\u201315.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"1439_CR2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11926-012-0260-8","volume":"14","author":"WH Boehncke","year":"2012","unstructured":"Boehncke WH, Boehncke S. Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives. Curr Rheumatol Rep. 2012;14(4):343\u20138.","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"1439_CR3","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N","volume":"41","author":"DD Gladman","year":"1998","unstructured":"Gladman DD, Farewell VT, Wong K, Husted J. Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum. 1998;41(6):1103\u201310.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1439_CR4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/ard.52.3.174","volume":"52","author":"K Lehtinen","year":"1993","unstructured":"Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis. 1993;52(3):174\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1439_CR5","first-page":"2167","volume":"33","author":"C Han","year":"2006","unstructured":"Han C, Robinson DW, Hackett MV, Paramore LC, Fraeman KH, Bala MV. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 2006;33(11):2167\u201372.","journal-title":"J Rheumatol"},{"issue":"2","key":"1439_CR6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0735-1097(97)00189-7","volume":"30","author":"DS Celermajer","year":"1997","unstructured":"Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol. 1997;30(2):325\u201333.","journal-title":"J Am Coll Cardiol"},{"issue":"10, Supplement","key":"1439_CR7","doi-asserted-by":"crossref","first-page":"L40","DOI":"10.1016\/S0002-9149(02)02963-6","volume":"90","author":"D Behrendt","year":"2002","unstructured":"Behrendt D, Ganz P. Endothelial function: from vascular biology to clinical applications. Am J Cardiol. 2002;90(10, Supplement 3):L40\u20138.","journal-title":"Am J Cardiol"},{"issue":"2","key":"1439_CR8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/art.22530","volume":"57","author":"C Gonzalez-Juanatey","year":"2007","unstructured":"Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA, Amigo-Diaz E, Testa A, Garcia-Porrua C, et al. Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum. 2007;57(2):287\u201393.","journal-title":"Arthritis Rheum"},{"issue":"29","key":"1439_CR9","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.2174\/1381612043382765","volume":"10","author":"S Nadar","year":"2004","unstructured":"Nadar S, Blann AD, Lip GY. Endothelial dysfunction: methods of assessment and application to hypertension. Curr Pharm Des. 2004;10(29):3591\u2013605.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"1439_CR10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/rheumatology\/kei145","volume":"45","author":"I Sari","year":"2006","unstructured":"Sari I, Okan T, Akar S, Cece H, Altay C, Secil M, et al. Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford). 2006;45(3):283\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1439_CR11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","volume":"23","author":"PO Bonetti","year":"2003","unstructured":"Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23(2):168\u201375.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"1439_CR12","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/acr.20371","volume":"63","author":"C Barnabe","year":"2011","unstructured":"Barnabe C, Martin BJ, Ghali WA. Systematic review and meta-analysis: anti-tumor necrosis factor alpha therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2011;63(4):522\u20139.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"1439_CR13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/rheumatology\/kep366","volume":"49","author":"SL Westlake","year":"2010","unstructured":"Westlake SL, Colebatch AN, Baird J, Kiely P, Quinn M, Choy E, et al. The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology (Oxford). 2010;49(2):295\u2013307.","journal-title":"Rheumatology (Oxford)"},{"key":"1439_CR14","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","volume":"106","author":"D H\u00fcrlimann","year":"2002","unstructured":"H\u00fcrlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O, B\u00e9chir M, Spieker LE, Neidhart M, Michel BA, Gay RE, L\u00fcscher TF, Gay S, Ruschitzka F, et al. Anti-tumor necrosis factor treatment improves endothelial function in patients with rheumatoid arthritis. Circulation. 2002;106:2184\u20137.","journal-title":"Circulation."},{"issue":"6","key":"1439_CR15","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ajh.2012.12","volume":"25","author":"K Angel","year":"2012","unstructured":"Angel K, Provan SA, Fagerhol MK, Mowinckel P, Kvien TK, Atar D. Effect of 1-year anti-TNF-\u03b1 therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study. Am J Hypertens. 2012;25(6):644\u201350.","journal-title":"Am J Hypertens"},{"issue":"2","key":"1439_CR16","doi-asserted-by":"crossref","first-page":"e0169830","DOI":"10.1371\/journal.pone.0169830","volume":"12","author":"G Deyab","year":"2017","unstructured":"Deyab G, Hokstad I, Whist JE, Smastuen MC, Agewall S, Lyberg T, et al. Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. PLoS One. 2017;12(2):e0169830.","journal-title":"PLoS One"},{"issue":"1","key":"1439_CR17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","volume":"3","author":"JMH Moll","year":"1973","unstructured":"Moll JMH, Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3(1):55\u201378.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"1439_CR18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361\u20138.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1439_CR19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315\u201324.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1439_CR20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jbspin.2006.01.007","volume":"73","author":"S Pavy","year":"2006","unstructured":"Pavy S, Constantin A, Pham T, Gossec L, Maillefert J-F, Cantagrel A, et al. Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine. 2006;73(4):388\u201395.","journal-title":"Joint Bone Spine"},{"issue":"2","key":"1439_CR21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.39298","volume":"68","author":"MM Ward","year":"2016","unstructured":"Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, et al. American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2016;68(2):282\u201398.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"1439_CR22","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/ard.2011.151563","volume":"70","author":"D Heijde van der","year":"2011","unstructured":"van der Heijde D, Sieper J, Maksymowych WP, Dougados M, Burgos-Vargas R, Landewe R, et al. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis. 2011;70(6):905\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1439_CR23","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0735-1097(03)00329-2","volume":"41","author":"PO Bonetti","year":"2003","unstructured":"Bonetti PO, Barsness GW, Keelan PC, Schnell TI, Pumper GM, Kuvin JT, et al. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol. 2003;41(10):1761\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"1439_CR24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/03009742.2012.656698","volume":"41","author":"G Hjeltnes","year":"2012","unstructured":"Hjeltnes G, Hollan I, F\u00f8rre \u00d8, Wiik A, Lyberg T, Mikkelsen K, Agewall S. Endothelial function improves within 6\u00a0weeks of treatment with methotrexate or methotrexate in combinition with a TNF -\u03b1 inhibitor in rheumatoid arthritis patients. Scand J Rheumatol. 2012;41:240\u20138.","journal-title":"Scand J Rheumatol."},{"key":"1439_CR25","first-page":"6813016","volume":"2016","author":"X Yang","year":"2016","unstructured":"Yang X, Chang Y, Wei W. Endothelial dysfunction and inflammation: immunity in rheumatoid arthritis. Mediators Inflamm. 2016;2016:6813016.","journal-title":"Mediators Inflamm."},{"key":"1439_CR26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1155\/2014\/312647","volume":"2014","author":"I Voloshyna","year":"2014","unstructured":"Voloshyna I, Seshadri S, Anwar K, Littlefield MJ, Belilos E, Carsons SE, et al. Infliximab reverses suppression of cholesterol efflux proteins by TNF-\u03b1: a possible mechanism for modulation of atherogenesis. Biomed Res Int. 2014;2014:8.","journal-title":"Biomed Res Int."},{"issue":"12","key":"1439_CR27","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1002\/art.24040","volume":"58","author":"AB Reiss","year":"2008","unstructured":"Reiss AB, Carsons SE, Anwar K, Rao S, Edelman SD, Zhang H, et al. Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte\/macrophages. Arthritis Rheum. 2008;58(12):3675\u201383.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1439_CR28","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/art.39039","volume":"67","author":"N Ronda","year":"2015","unstructured":"Ronda N, Greco D, Adorni MP, Zimetti F, Favari E, Hjeltnes G, et al. Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism. Arthritis Rheumatol. 2015;67(5):1155\u201364.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"1439_CR29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MOL.0b013e328352c4dd","volume":"23","author":"HC Prosser","year":"2012","unstructured":"Prosser HC, Ng MK, Bursill CA. The role of cholesterol efflux in mechanisms of endothelial protection by HDL. Curr Opin Lipidol. 2012;23(3):182\u20139.","journal-title":"Curr Opin Lipidol"},{"issue":"11","key":"1439_CR30","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1172\/JCI35470","volume":"118","author":"N Terasaka","year":"2008","unstructured":"Terasaka N, Yu S, Yvan-Charvet L, Wang N, Mzhavia N, Langlois R, et al. ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet. J Clin Invest. 2008;118(11):3701\u201313.","journal-title":"J Clin Invest"},{"issue":"11","key":"1439_CR31","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/ATVBAHA.110.213215","volume":"30","author":"N Terasaka","year":"2010","unstructured":"Terasaka N, Westerterp M, Koetsveld J, Fernandez-Hernando C, Yvan-Charvet L, Wang N, et al. ATP-binding cassette transporter G1 and high-density lipoprotein promote endothelial NO synthesis through a decrease in the interaction of caveolin-1 and endothelial NO synthase. Arterioscler Thromb Vasc Biol. 2010;30(11):2219\u201325.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"1439_CR32","doi-asserted-by":"crossref","first-page":"C739","DOI":"10.1152\/ajpcell.00055.2011","volume":"301","author":"D Liu","year":"2011","unstructured":"Liu D, Ji L, Tong X, Pan B, Han JY, Huang Y, et al. Human apolipoprotein A-I induces cyclooxygenase-2 expression and prostaglandin I-2 release in endothelial cells through ATP-binding cassette transporter A1. Am J Physiol Cell Physiol. 2011;301(3):C739\u201348.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"7","key":"1439_CR33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.numecd.2014.02.010","volume":"24","author":"GB Vigna","year":"2014","unstructured":"Vigna GB, Satta E, Bernini F, Boarini S, Bosi C, Giusto L, et al. Flow-mediated dilation, carotid wall thickness and HDL function in subjects with hyperalphalipoproteinemia. Nutr Metab Cardiovasc Dis. 2014;24(7):777\u201383.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"1439_CR34","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/art.39574","volume":"68","author":"A Ahmed","year":"2016","unstructured":"Ahmed A, Hollan I, Curran SA, Kitson SM, Riggio MP, Mikkelsen K, et al. Brief report: proatherogenic cytokine microenvironment in the aortic adventitia of patients with rheumatoid arthritis. Arthritis Rheumatol. 2016;68(6):1361\u20136.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"1439_CR35","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/art.38393","volume":"66","author":"MA Shelef","year":"2014","unstructured":"Shelef MA, Sokolove J, Lahey LJ, Wagner CA, Sackmann EK, Warner TF, et al. Peptidylarginine deiminase 4 contributes to tumor necrosis factor alpha-induced inflammatory arthritis. Arthritis Rheumatol. 2014;66(6):1482\u201391.","journal-title":"Arthritis Rheumatol"},{"key":"1439_CR36","doi-asserted-by":"crossref","first-page":"281240","DOI":"10.4061\/2011\/281240","volume":"2011","author":"C Savoia","year":"2011","unstructured":"Savoia C, Sada L, Zezza L, Pucci L, Lauri FM, Befani A, et al. Vascular inflammation and endothelial dysfunction in experimental hypertension. Int J Hypertens. 2011;2011:281240.","journal-title":"Int J Hypertens."},{"issue":"7141","key":"1439_CR37","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1136\/bmj.316.7141.1328","volume":"316","author":"BJ Hunt","year":"1998","unstructured":"Hunt BJ, Jurd KM. Endothelial cell activation: a central pathophysiological process. BMJ. 1998;316(7141):1328\u20139.","journal-title":"BMJ"},{"issue":"10","key":"1439_CR38","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","volume":"115","author":"JE Deanfield","year":"2007","unstructured":"Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115(10):1285\u201395.","journal-title":"Circulation"},{"issue":"2","key":"1439_CR39","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clim.2004.09.001","volume":"114","author":"A Johnston","year":"2005","unstructured":"Johnston A, Gudjonsson JE, Sigmundsdottir H, Ludviksson BR, Valdimarsson H. The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules. Clin Immunol. 2005;114(2):154\u201363.","journal-title":"Clin Immunol"},{"issue":"6","key":"1439_CR40","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2217\/imt.10.67","volume":"2","author":"LC Silva","year":"2010","unstructured":"Silva LC, Ortigosa LC, Benard G. Anti-TNF-alpha agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls. Immunotherapy. 2010;2(6):817\u201333.","journal-title":"Immunotherapy"},{"issue":"1","key":"1439_CR41","first-page":"36","volume":"52","author":"PA Klimiuk","year":"2004","unstructured":"Klimiuk PA, Sierakowski S, Domyslawska I, Fiedorczyk M, Chwiecko J. Reduction of soluble adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor levels in serum of rheumatoid arthritis patients following multiple intravenous infusions of infliximab. Arch Immunol Ther Exp (Warsz). 2004;52(1):36\u201342.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"3","key":"1439_CR42","first-page":"415","volume":"31","author":"G Hjeltnes","year":"2013","unstructured":"Hjeltnes G, Hollan I, Forre O, Wiik A, Lyberg T, Mikkelsen K, et al. Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-alpha-inhibitor. Clin Exp Rheumatol. 2013;31(3):415\u201321.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"1439_CR43","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1089\/gtmb.2015.0255","volume":"20","author":"Z Huang","year":"2016","unstructured":"Huang Z, Chen C, Li S, Kong F, Shan P, Huang W. Serum markers of endothelial dysfunction and inflammation increase in hypertension with prediabetes mellitus. Genet Test Mol Biomarkers. 2016;20(6):322\u20137.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"1","key":"1439_CR44","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1038\/s41598-017-05759-2","volume":"7","author":"F Ursini","year":"2017","unstructured":"Ursini F, Leporini C, Bene F, D'Angelo S, Mauro D, Russo E, et al. Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis. Sci Rep. 2017;7(1):5346.","journal-title":"Sci Rep"},{"issue":"6","key":"1439_CR45","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/art.22690","volume":"56","author":"I Hollan","year":"2007","unstructured":"Hollan I, Scott H, Saatvedt K, Prayson R, Mikkelsen K, Nossent HC, et al. Inflammatory rheumatic disease and smoking are predictors of aortic inflammation: a controlled study of biopsy specimens obtained at coronary artery surgery. Arthritis Rheum. 2007;56(6):2072\u20139.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1439_CR46","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/ard.2007.086777","volume":"68","author":"IC Eijk van","year":"2009","unstructured":"van Eijk IC, Peters MJ, Serne EH, van der Horst-Bruinsma IE, Dijkmans BA, Smulders YM, et al. Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor alpha blockade. Ann Rheum Dis. 2009;68(3):362\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1439_CR47","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/138161282004140213123852","volume":"20","author":"EA Brezinski","year":"2014","unstructured":"Brezinski EA, Follansbee MR, Armstrong EJ, Armstrong AW. Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review. Curr Pharm Des. 2014;20(4):513\u201328.","journal-title":"Curr Pharm Des"},{"issue":"2","key":"1439_CR48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/rheumatology\/ket260","volume":"53","author":"M Jani","year":"2014","unstructured":"Jani M, Barton A, Warren RB, Griffiths CE, Chinoy H. The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases. Rheumatology (Oxford). 2014;53(2):213\u201322.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1439-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T16:07:25Z","timestamp":1570205245000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1439-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,17]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1439"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1439-1","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,17]]},"article-number":"232"}}